These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35678846)

  • 1. [Arm swelling and dyspnea under ongoing treatment with rivaroxaban].
    Gröning I; Fundel B; Deuster RJ; Thomas C; Westphal J
    Med Klin Intensivmed Notfmed; 2022 Sep; 117(6):469-472. PubMed ID: 35678846
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication mismanagement using the rivaroxaban demonstration pack.
    Nguyen TT; MacLasco A; Vitto MJ
    Am J Health Syst Pharm; 2017 Jun; 74(12):872-873. PubMed ID: 28596224
    [No Abstract]   [Full Text] [Related]  

  • 3. Heavy menstrual bleeding on rivaroxaban.
    Ferreira M; Barsam S; Patel JP; Czuprynska J; Roberts LN; Patel RK; Arya R
    Br J Haematol; 2016 Apr; 173(2):314-5. PubMed ID: 26212626
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver injury during rivaroxaban treatment in a patient with AL amyloidosis.
    Marrinan A; Shackleton L; Kelly C; Lavin M; Glavey S; Murphy P; Quinn J
    Eur J Clin Pharmacol; 2021 Jul; 77(7):1073-1076. PubMed ID: 33427957
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban.
    Chung EY; Chen J; Roxburgh S
    Nephrology (Carlton); 2018 Mar; 23(3):289-290. PubMed ID: 29461002
    [No Abstract]   [Full Text] [Related]  

  • 6. Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
    Okumura Y; Fukuda I; Nakamura M; Yamada N; Takayama M; Maeda H; Yamashita T; Ikeda T; Mo M; Yamazaki T; Hirayama A;
    BMJ Open; 2018 Jun; 8(6):e020286. PubMed ID: 29934383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.
    Lindner SM; Fordyce CB; Hellkamp AS; Lokhnygina Y; Piccini JP; Breithardt G; Mahaffey KW; Singer DE; Hacke W; Halperin JL; Hankey GJ; Berkowitz SD; Nessel CC; Becker RC; Fox KA; Patel MR;
    Circulation; 2017 Mar; 135(10):1001-1003. PubMed ID: 28264892
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism.
    Lim MS; Nandurkar D; Jong I; Cummins A; Tran H; Chunilal S
    J Thromb Thrombolysis; 2020 Feb; 49(2):220-227. PubMed ID: 31493288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.
    Singer AJ; Xiang J; Kabrhel C; Merli GJ; Pollack C; Tapson VF; Wildgoose P; Peacock WF
    Acad Emerg Med; 2016 Nov; 23(11):1280-1286. PubMed ID: 27537530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists.
    Eerenberg ES; Middeldorp S; Levi M; Lensing AW; Büller HR
    J Thromb Haemost; 2015 Sep; 13(9):1590-6. PubMed ID: 26179293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rivaroxaban plus Percutaneous catheter-directed treatment for a patient with massive pulmonary embolism and colporrhagia.
    Wang W
    Am J Emerg Med; 2018 Aug; 36(8):1522.e5-1522.e7. PubMed ID: 29709396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
    Vavlukis M; Kotlar I; Taravari H; Poposka L; Kedev S
    Anatol J Cardiol; 2017 Jul; 18(1):77-79. PubMed ID: 28680014
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified Pulmonary Embolism Severity Index score from a post hoc analysis of the EINSTEIN PE study.
    Fermann GJ; Erkens PM; Prins MH; Wells PS; Pap ÁF; Lensing AW
    Acad Emerg Med; 2015 Mar; 22(3):299-307. PubMed ID: 25716463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.
    Glikson E; Chavkin U; Madgar O; Sagiv D; Nakache G; Yakirevitch A; Wolf M; Alon EE
    Laryngoscope; 2019 Jan; 129(1):119-123. PubMed ID: 30325496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
    Jun JH; Hwang JC
    JAMA Ophthalmol; 2015 Oct; 133(10):1184-6. PubMed ID: 26111247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidly Obese Patient on Rivaroxaban Presents With Recurrent Upper Extremity Deep Vein Thrombosis: A Case Report.
    Jennings ST; Manh KNP; Bita J
    J Pharm Pract; 2020 Oct; 33(5):712-719. PubMed ID: 31232154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.